Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression.

Quirico L, Orso F, Esposito CL, Bertone S, Coppo R, Conti L, Catuogno S, Cavallo F, de Franciscis V, Taverna D.

Int J Biol Sci. 2020 Feb 10;16(7):1238-1251. doi: 10.7150/ijbs.39768. eCollection 2020.

2.

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.

Ferreira LC, Orso F, Dettori D, Lacerda JZ, Borin TF, Taverna D, Zuccari DAPC.

PLoS One. 2020 Feb 3;15(2):e0228062. doi: 10.1371/journal.pone.0228062. eCollection 2020.

3.

Polarization Selectivity in Vibrational Electron-Energy-Loss Spectroscopy.

Radtke G, Taverna D, Menguy N, Pandolfi S, Courac A, Le Godec Y, Krivanek OL, Lovejoy TC.

Phys Rev Lett. 2019 Dec 20;123(25):256001. doi: 10.1103/PhysRevLett.123.256001.

PMID:
31922788
4.

Investigating the epi-miRNome: identification of epi-miRNAs using transfection experiments.

Reale E, Taverna D, Cantini L, Martignetti L, Osella M, De Pittà C, Virga F, Orso F, Caselle M.

Epigenomics. 2019 Nov;11(14):1581-1599. doi: 10.2217/epi-2019-0050. Epub 2019 Nov 6.

5.

Carbon-Nanotube-Supported Copper Polyphthalocyanine for Efficient and Selective Electrocatalytic CO2 Reduction to CO.

Karapinar D, Zitolo A, Huan TN, Zanna S, Taverna D, Galvão Tizei LH, Giaume D, Marcus P, Mougel V, Fontecave M.

ChemSusChem. 2020 Jan 9;13(1):173-179. doi: 10.1002/cssc.201902859. Epub 2019 Nov 14.

PMID:
31622012
6.

Electroreduction of CO2 on Single-Site Copper-Nitrogen-Doped Carbon Material: Selective Formation of Ethanol and Reversible Restructuration of the Metal Sites.

Karapinar D, Huan NT, Ranjbar Sahraie N, Li J, Wakerley D, Touati N, Zanna S, Taverna D, Galvão Tizei LH, Zitolo A, Jaouen F, Mougel V, Fontecave M.

Angew Chem Int Ed Engl. 2019 Oct 14;58(42):15098-15103. doi: 10.1002/anie.201907994. Epub 2019 Sep 11. Review.

PMID:
31453650
7.

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.

Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.

Oncotarget. 2019 Aug 13;10(48):5003-5004. doi: 10.18632/oncotarget.27151. eCollection 2019 Aug 13.

8.

Role of miRNAs in tumor and endothelial cell interactions during tumor progression.

Orso F, Quirico L, Dettori D, Coppo R, Virga F, Ferreira LC, Paoletti C, Baruffaldi D, Penna E, Taverna D.

Semin Cancer Biol. 2020 Feb;60:214-224. doi: 10.1016/j.semcancer.2019.07.024. Epub 2019 Aug 3. Review.

PMID:
31386907
9.

Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells.

Parrotta EI, Scalise S, Taverna D, De Angelis MT, Sarro G, Gaspari M, Santamaria G, Cuda G.

J Cell Mol Med. 2019 Aug;23(8):5440-5453. doi: 10.1111/jcmm.14426. Epub 2019 Jun 25.

10.

Room Temperature Blocked Magnetic Nanoparticles Based on Ferrite Promoted by a Three-Step Thermal Decomposition Process.

Sartori K, Choueikani F, Gloter A, Begin-Colin S, Taverna D, Pichon BP.

J Am Chem Soc. 2019 Jun 26;141(25):9783-9787. doi: 10.1021/jacs.9b03965. Epub 2019 Jun 14.

PMID:
31149820
11.

Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids.

Meleddu R, Petrikaite V, Distinto S, Arridu A, Angius R, Serusi L, Škarnulytė L, Endriulaitytė U, Paškevičiu Tė M, Cottiglia F, Gaspari M, Taverna D, Deplano S, Fois B, Maccioni E.

ACS Med Chem Lett. 2018 Dec 18;10(4):571-576. doi: 10.1021/acsmedchemlett.8b00596. eCollection 2019 Apr 11.

PMID:
30996798
12.

Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma.

Vitiello M, Evangelista M, Di Lascio N, Kusmic C, Massa A, Orso F, Sarti S, Marranci A, Rodzik K, Germelli L, Chandra D, Salvetti A, Pucci A, Taverna D, Faita F, Gravekamp C, Poliseno L.

Oncogene. 2019 May;38(19):3756-3762. doi: 10.1038/s41388-019-0681-1. Epub 2019 Jan 21.

13.

Zn-Cu Alloy Nanofoams as Efficient Catalysts for the Reduction of CO2 to Syngas Mixtures with a Potential-Independent H2 /CO Ratio.

Lamaison S, Wakerley D, Montero D, Rousse G, Taverna D, Giaume D, Mercier D, Blanchard J, Tran HN, Fontecave M, Mougel V.

ChemSusChem. 2019 Jan 24;12(2):511-517. doi: 10.1002/cssc.201802287. Epub 2019 Jan 14.

PMID:
30637969
14.

AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC.

Laudadio I, Orso F, Azzalin G, Calabrò C, Berardinelli F, Coluzzi E, Gioiosa S, Taverna D, Sgura A, Carissimi C, Fulci V.

EMBO Rep. 2019 Feb;20(2). pii: e45969. doi: 10.15252/embr.201845969. Epub 2018 Dec 27.

15.

On-Tissue Hydrogel-Mediated Nondestructive Proteomic Characterization: Application to fr/fr and FFPE Tissues and Insights for Quantitative Proteomics Using a Case of Cardiac Myxoma.

Taverna D, Mignogna C, Santise G, Gaspari M, Cuda G.

Proteomics Clin Appl. 2019 Jan;13(1):e1700167. doi: 10.1002/prca.201700167. Epub 2018 Nov 12.

PMID:
30387291
16.

Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides.

Meleddu R, Distinto S, Cottiglia F, Angius R, Gaspari M, Taverna D, Melis C, Angeli A, Bianco G, Deplano S, Fois B, Del Prete S, Capasso C, Alcaro S, Ortuso F, Yanez M, Supuran CT, Maccioni E.

ACS Med Chem Lett. 2018 Sep 17;9(10):1045-1050. doi: 10.1021/acsmedchemlett.8b00352. eCollection 2018 Oct 11.

17.

Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression.

Li X, Shepard HM, Cowell JA, Zhao C, Osgood RJ, Rosengren S, Blouw B, Garrovillo SA, Pagel MD, Whatcott CJ, Han H, Von Hoff DD, Taverna DM, LaBarre MJ, Maneval DC, Thompson CB.

Clin Cancer Res. 2018 Oct 1;24(19):4798-4807. doi: 10.1158/1078-0432.CCR-17-3284. Epub 2018 Jul 3.

18.

Targeting Tumor Associated Carbonic Anhydrases IX and XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors.

Melis C, Distinto S, Bianco G, Meleddu R, Cottiglia F, Fois B, Taverna D, Angius R, Alcaro S, Ortuso F, Gaspari M, Angeli A, Del Prete S, Capasso C, Supuran CT, Maccioni E.

ACS Med Chem Lett. 2018 Jun 6;9(7):725-729. doi: 10.1021/acsmedchemlett.8b00170. eCollection 2018 Jul 12.

19.

Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.

Dettori D, Orso F, Penna E, Baruffaldi D, Brundu S, Maione F, Turco E, Giraudo E, Taverna D.

Mol Ther. 2018 Aug 1;26(8):2008-2018. doi: 10.1016/j.ymthe.2018.05.020.

20.

Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V, Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A, Boehm J, Boutron-Ruault MC, Brenner H, Brezina S, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castelao JE, Chan AT, Chang-Claude J, Chanock SJ, Cheng I, Cheng YW, Chin LS, Church JM, Church T, Coetzee GA, Cotterchio M, Cruz Correa M, Curtis KR, Duggan D, Easton DF, English D, Feskens EJM, Fischer R, FitzGerald LM, Fortini BK, Fritsche LG, Fuchs CS, Gago-Dominguez M, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Giovannucci EL, Gogarten SM, Gonzalez-Villalpando C, Gonzalez-Villalpando EM, Grady WM, Greenson JK, Gsur A, Gunter M, Haiman CA, Hampe J, Harlid S, Harju JF, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Huang SC, Huerta JM, Hudson TJ, Hunter DJ, Idos GE, Iwasaki M, Jackson RD, Jacobs EJ, Jee SH, Jenkins MA, Jia WH, Jiao S, Joshi AD, Kolonel LN, Kono S, Kooperberg C, Krogh V, Kuehn T, Küry S, LaCroix A, Laurie CA, Lejbkowicz F, Lemire M, Lenz HJ, Levine D, Li CI, Li L, Lieb W, Lin Y, Lindor NM, Liu YR, Loupakis F, Lu Y, Luh F, Ma J, Mancao C, Manion FJ, Markowitz SD, Martin V, Matsuda K, Matsuo K, McDonnell KJ, McNeil CE, Milne R, Molina AJ, Mukherjee B, Murphy N, Newcomb PA, Offit K, Omichessan H, Palli D, Cotoré JPP, Pérez-Mayoral J, Pharoah PD, Potter JD, Qu C, Raskin L, Rennert G, Rennert HS, Riggs BM, Schafmayer C, Schoen RE, Sellers TA, Seminara D, Severi G, Shi W, Shibata D, Shu XO, Siegel EM, Slattery ML, Southey M, Stadler ZK, Stern MC, Stintzing S, Taverna D, Thibodeau SN, Thomas DC, Trichopoulou A, Tsugane S, Ulrich CM, van Duijnhoven FJB, van Guelpan B, Vijai J, Virtamo J, Weinstein SJ, White E, Win AK, Wolk A, Woods M, Wu AH, Wu K, Xiang YB, Yen Y, Zanke BW, Zeng YX, Zhang B, Zubair N, Kweon SS, Figueiredo JC, Zheng W, Marchand LL, Lindblom A, Moreno V, Peters U, Casey G, Hsu L, Conti DV, Gruber SB.

J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.

21.

Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Bellazzo A, Di Minin G, Valentino E, Sicari D, Torre D, Marchionni L, Serpi F, Stadler MB, Taverna D, Zuccolotto G, Montagner IM, Rosato A, Tonon F, Zennaro C, Agostinis C, Bulla R, Mano M, Del Sal G, Collavin L.

Cell Death Differ. 2018 Jul;25(7):1224-1238. doi: 10.1038/s41418-018-0088-5. Epub 2018 Mar 22.

22.

IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.

Lombardo G, Gili M, Grange C, Cavallari C, Dentelli P, Togliatto G, Taverna D, Camussi G, Brizzi MF.

Oncogene. 2018 Mar;37(9):1175-1191. doi: 10.1038/s41388-017-0034-x. Epub 2017 Dec 14.

23.

Aromatherapy: composition of the gaseous phase at equilibrium with liquid bergamot essential oil.

Leggio A, Leotta V, Belsito EL, Di Gioia ML, Romio E, Santoro I, Taverna D, Sindona G, Liguori A.

Chem Cent J. 2017 Nov 2;11(1):111. doi: 10.1186/s13065-017-0340-y.

24.

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition.

Xue G, Kohler R, Tang F, Hynx D, Wang Y, Orso F, Prêtre V, Ritschard R, Hirschmann P, Cron P, Roloff T, Dummer R, Mandalà M, Bichet S, Genoud C, Meyer AG, Muraro MG, Spagnoli GC, Taverna D, Rüegg C, Merghoub T, Massi D, Tang H, Levesque MP, Dirnhofer S, Zippelius A, Hemmings BA, Wicki A.

Oncotarget. 2017 May 25;8(41):69204-69218. doi: 10.18632/oncotarget.18213. eCollection 2017 Sep 19.

25.

N-Acylbenzenesulfonamide Dihydro-1,3,4-oxadiazole Hybrids: Seeking Selectivity toward Carbonic Anhydrase Isoforms.

Bianco G, Meleddu R, Distinto S, Cottiglia F, Gaspari M, Melis C, Corona A, Angius R, Angeli A, Taverna D, Alcaro S, Leitans J, Kazaks A, Tars K, Supuran CT, Maccioni E.

ACS Med Chem Lett. 2017 Jun 21;8(8):792-796. doi: 10.1021/acsmedchemlett.7b00205. eCollection 2017 Aug 10.

26.

First-Principles Vibrational Electron Energy Loss Spectroscopy of β-Guanine.

Radtke G, Taverna D, Lazzeri M, Balan E.

Phys Rev Lett. 2017 Jul 14;119(2):027402. doi: 10.1103/PhysRevLett.119.027402. Epub 2017 Jul 13.

PMID:
28753326
27.

Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.

Sciortino M, Camacho-Leal MDP, Orso F, Grassi E, Costamagna A, Provero P, Tam W, Turco E, Defilippi P, Taverna D, Cabodi S.

Sci Rep. 2017 Apr 25;7(1):1145. doi: 10.1038/s41598-017-01332-z.

28.

Rapid assay of resveratrol in red wine by paper spray tandem mass spectrometry and isotope dilution.

Di Donna L, Taverna D, Indelicato S, Napoli A, Sindona G, Mazzotti F.

Food Chem. 2017 Aug 15;229:354-357. doi: 10.1016/j.foodchem.2017.02.098. Epub 2017 Feb 21.

PMID:
28372185
29.

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p.

Audrito V, Serra S, Stingi A, Orso F, Gaudino F, Bologna C, Neri F, Garaffo G, Nassini R, Baroni G, Rulli E, Massi D, Oliviero S, Piva R, Taverna D, Mandalà M, Deaglio S.

Oncotarget. 2017 Feb 28;8(9):15894-15911. doi: 10.18632/oncotarget.15213.

30.

An optimized procedure for on-tissue localized protein digestion and quantification using hydrogel discs and isobaric mass tags: analysis of cardiac myxoma.

Taverna D, Mignogna C, Gabriele C, Santise G, Donato G, Cuda G, Gaspari M.

Anal Bioanal Chem. 2017 Apr;409(11):2919-2930. doi: 10.1007/s00216-017-0237-6. Epub 2017 Feb 11.

PMID:
28190108
31.

The RNA-binding protein ESRP1 promotes human colorectal cancer progression.

Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfò I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F.

Oncotarget. 2017 Feb 7;8(6):10007-10024. doi: 10.18632/oncotarget.14318.

32.

VEGF blockade enhances the antitumor effect of BRAFV600E inhibition.

Comunanza V, Corà D, Orso F, Consonni FM, Middonti E, Di Nicolantonio F, Buzdin A, Sica A, Medico E, Sangiolo D, Taverna D, Bussolino F.

EMBO Mol Med. 2017 Feb;9(2):219-237. doi: 10.15252/emmm.201505774.

33.

Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting.

Gallo S, Gili M, Lombardo G, Rossetti A, Rosso A, Dentelli P, Togliatto G, Deregibus MC, Taverna D, Camussi G, Brizzi MF.

PLoS One. 2016 Sep 9;11(9):e0162417. doi: 10.1371/journal.pone.0162417. eCollection 2016.

34.

Rapid discrimination of bergamot essential oil by paper spray mass spectrometry and chemometric analysis.

Taverna D, Di Donna L, Mazzotti F, Tagarelli A, Napoli A, Furia E, Sindona G.

J Mass Spectrom. 2016 Sep;51(9):761-7. doi: 10.1002/jms.3820.

PMID:
27460885
35.

miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.

Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, Deaglio S, Brizzi MF, Stadler MB, Provero P, Caselle M, Taverna D.

Cancer Res. 2016 Sep 1;76(17):5151-62. doi: 10.1158/0008-5472.CAN-15-1322. Epub 2016 Jun 21.

36.

miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization.

Raimo M, Orso F, Grassi E, Cimino D, Penna E, De Pittà C, Stadler MB, Primo L, Calautti E, Quaglino P, Provero P, Taverna D.

Mol Cancer Res. 2016 Jun;14(6):548-62. doi: 10.1158/1541-7786.MCR-15-0425-T.

37.

High-Pressure Control of Vanadium Self-Intercalation and Enhanced Metallic Properties in 1T-V1+xS2 Single Crystals.

Moutaabbid H, Le Godec Y, Taverna D, Baptiste B, Klein Y, Loupias G, Gauzzi A.

Inorg Chem. 2016 Jul 5;55(13):6481-6. doi: 10.1021/acs.inorgchem.6b00532. Epub 2016 Jun 14.

PMID:
27300759
38.

Imaging mass spectrometry for accessing molecular changes during burn wound healing.

Taverna D, Pollins AC, Sindona G, Caprioli RM, Nanney LB.

Wound Repair Regen. 2016 Sep;24(5):775-785. doi: 10.1111/wrr.12450. Epub 2016 Jul 26.

PMID:
27256813
39.

Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.

Wicki A, Mandalà M, Massi D, Taverna D, Tang H, Hemmings BA, Xue G.

Physiol Rev. 2016 Jul;96(3):805-29. doi: 10.1152/physrev.00024.2015. Review.

40.

CyTRANSFINDER: a Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction.

Politano G, Orso F, Raimo M, Benso A, Savino A, Taverna D, Di Carlo S.

BMC Bioinformatics. 2016 Apr 8;17:157. doi: 10.1186/s12859-016-0964-2.

41.

Fast analysis of caffeine in beverages and drugs by paper spray tandem mass spectrometry.

Taverna D, Di Donna L, Bartella L, Napoli A, Sindona G, Mazzotti F.

Anal Bioanal Chem. 2016 May;408(14):3783-7. doi: 10.1007/s00216-016-9468-1. Epub 2016 Mar 22.

PMID:
27002611
42.

Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.

Nat Commun. 2015 Oct 26;6:8739. doi: 10.1038/ncomms9739. No abstract available.

PMID:
26498495
43.

Histology-guided protein digestion/extraction from formalin-fixed and paraffin-embedded pressure ulcer biopsies.

Taverna D, Pollins AC, Nanney LB, Sindona G, Caprioli RM.

Exp Dermatol. 2016 Feb;25(2):143-6. doi: 10.1111/exd.12870. Epub 2015 Nov 23.

44.

Genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.

Nat Commun. 2015 Jul 7;6:7138. doi: 10.1038/ncomms8138. Erratum in: Nat Commun. 2015;6:8739. Kury, Sebastian; Giocannucci, Edward L. and Lemire, Mathiew [Corrected to Küry, Sébastien; Giovannucci, Edward L. and Lemire, Mathieu].

45.

Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.

Khalili H, Gong J, Brenner H, Austin TR, Hutter CM, Baba Y, Baron JA, Berndt SI, Bézieau S, Caan B, Campbell PT, Chang-Claude J, Chanock SJ, Chen C, Hsu L, Jiao S, Conti DV, Duggan D, Fuchs CS, Gala M, Gallinger S, Haile RW, Harrison TA, Hayes R, Hazra A, Henderson B, Haiman C, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Küry S, LaCroix A, Marchand LL, Lemire M, Lindor NM, Ma J, Manson JE, Morikawa T, Nan H, Ng K, Newcomb PA, Nishihara R, Potter JD, Qu C, Schoen RE, Schumacher FR, Seminara D, Taverna D, Thibodeau S, Wactawski-Wende J, White E, Wu K, Zanke BW, Casey G, Hudson TJ, Kraft P, Peters U, Slattery ML, Ogino S, Chan AT; GECCO and CCFR.

Carcinogenesis. 2015 Sep;36(9):999-1007. doi: 10.1093/carcin/bgv086. Epub 2015 Jun 12.

46.

Determination of ketosteroid hormones in meat by liquid chromatography tandem mass spectrometry and derivatization chemistry.

Di Donna L, Benabdelkamel H, Taverna D, Indelicato S, Aiello D, Napoli A, Sindona G, Mazzotti F.

Anal Bioanal Chem. 2015 Jul;407(19):5835-42. doi: 10.1007/s00216-015-8772-5. Epub 2015 May 27.

PMID:
26014285
47.

Synthesis of Trimagnetic Multishell MnFe2 O4 @CoFe2 O4 @NiFe2 O4 Nanoparticles.

Gavrilov-Isaac V, Neveu S, Dupuis V, Taverna D, Gloter A, Cabuil V.

Small. 2015 Jun 10;11(22):2614-8. doi: 10.1002/smll.201402845. Epub 2015 Feb 12.

PMID:
25684735
48.

Histology-directed and imaging mass spectrometry: An emerging technology in ectopic calcification.

Taverna D, Boraldi F, De Santis G, Caprioli RM, Quaglino D.

Bone. 2015 May;74:83-94. doi: 10.1016/j.bone.2015.01.004. Epub 2015 Jan 13.

49.

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.

Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.

Oncotarget. 2015 Feb 10;6(4):2315-30. Erratum in: Oncotarget. 2019 Aug 13;10(48):5003-5004.

50.

MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis.

Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE.

Cell Stem Cell. 2014 Dec 4;15(6):762-74. doi: 10.1016/j.stem.2014.10.001. Epub 2014 Oct 16.

Supplemental Content

Loading ...
Support Center